Programming - Hypertension Scientific Sessions
Marriott Baltimore Waterfront | Baltimore, Maryland
Hypertension 2025 Schedule-at-a-Glance
Time | Activity |
---|---|
6:00 pm to 7:00 pm | Hypertension Journal Meet the Editors Networking Event |
7:00 pm to 9:00 pm | Opening Reception and Networking Session |
Time | Activity |
---|---|
7:30 am to 8:00 am | Welcome and Opening Remarks |
8:00 am to 10:00 am | Session 1 8:00 to 8:35 8:35 to 9:35 9:35 to 10:00 |
10:00 am to 10:30 am | Break |
10:30 am to 12:00 pm |
Session 2 - Concurrent Sessions A, B and C Concurrent A: Vascular Biology Vascular Biology Concurrent B: Pregnancy & Preeclampsia Novel Medical Imaging Methods in the Placenta Concurrent C: Blood Pressure Monitoring Blood Pressure Monitoring |
12:00 pm to 1:00 pm | Session 3 Meet the Guideline Keynote Speaker and Panel Networking Event |
1:00 pm to 1:30 pm | Sponsored Learning Studio Astra Zeneca |
1:30 pm to 3:00 pm | Session 4
1:30 to 2:00 2:00 to 3:00 |
3:00 pm to 3:30 pm | Break |
3:30 pm to 5:30 pm | Session 5
Concurrent A: Unlocking the Cardiometabolic Code of Hypertension Concurrent B: Let's Get Specific: Sex Differences, Dimorphisms, and Disparities in Hypertension Concurrent C 3:30 to 4:30 p.m. 3:30 3:40 3:50 4:00 4:10-4:30 4:30 to 5:30 p.m. 4:30 4:42 4:54 5:06 5:18 to 5:30 |
5:30 pm to 7:00 pm | Poster Session 1 and Reception Includes the TAC Poster Competition |
Time | Activity |
---|---|
7:00 am to 8:00 am | Session 6 Inside the AHA's Research Enterprise: Grant Funding and Other Opportunities |
7:15 am to 7:45 am | Sponsored Learning Studio Recor Medical |
8:00 am to 9:00 am |
Session 7 Speakers: |
9:00 am to 10:30 am | Poster Session 2 With Breakfast Reception |
10:30 am to 12:00 pm |
Session 8 Concurrent Session A: TAC Oral Abstract Award Competition Concurrent Session B: Molecular Highways: New Paths in Vascular Biology Concurrent Session C: Unpacking the 2025 AHA/ACC High Blood Pressure Guideline: What’s New and What It Means for Your Practice
(Clinical Science/Clinical Practice track programming)
|
12:00 pm to 1:30 pm | Session 9 CHAMP Lunch Event |
12:30 pm to 1:00 pm | Sponsored Learning Studio Medtronic |
1:30 pm to 3:00 pm |
Session 10 Concurrent A: Oxidative Stress, Inflammation, Immunity and Cytokines Angiotensin II-induced Hypertension Promotes Innate Immune Memory and Predisposes to Atherosclerosis Progression Concurrent B: Neurogenic Mechanisms Cognitive Function in Hypertension: Visualization by Advanced MRT Techniques Concurrent C: Rapid-Fire Cases: Burning Questions You’ve Always Wanted to Ask a Hypertension Specialist Partial list of presenters: Panelists: |
3:00 pm to 3:30 pm | Break |
3:30 pm to 5:30 pm | Session 11 Annual Hypertension Awards Session Includes:
|
5:30 pm to 6:30 pm |
Session 12 |
7:00 pm to 10:00 pm | Trainee Advocacy Mixer Event |
Time | Activity |
---|---|
7:00 am to 7:30 am | Sponsored Learning Studio Idorsia |
7:30 am to 9:00 am | Session 13
7:30 to 8:00 8:00 to 9:00 |
9:00 am to 10:00 am |
Session 14 Concurrent A: Sex and Gender Differences in Hypertension Concurrent B: Mineralocorticoid Receptors, Inflammation, Obesity and Cardiovascular Disease Concurrent C: Hypertension Journal Programming 9:00 9:30
|
10:00 am to 10:30 am | Break |
10:30 am to 12:00 pm |
Session 15 Concurrent A: Renin Angiotensin System Invited Lecture: Renin Angiotensin Concurrent B: Hypertension and Aging Invited Lecture: Hypertension and Aging Concurrent C: GLP1 and SGLT-2 and Hypertension Invited Lecture: GLP1 and SGLT-2 |
12:30 pm to 1:00 pm | Sponsored Learning Studio Corcept Therapeutics |
1:00 pm to 1:30 pm | Sponsored Learning Studio Mineralys Therapeutics |
12:00 pm to 1:30 pm | Lunch on Your Own |
1:30 pm to 3:00 pm |
Session 16 Concurent Session A: Genetics, Proteomics, and Metabolomics Invited Lecture: PRDM6 and Hypertension Concurrent Session B: Cardio-Renal Disease Invited Lecture: Extra Cellular Vesicles in Reno Cardiac Axis Concurrent Session C: Hypertension Across the Lifespan 1:30 1:50 2:10 2:30 2:50 - 3:00 |
3:00 pm to 3:30 pm | Break |
3:30 pm to 5:30 pm |
Session 17 3:30 to 4:30 4:30-5:30 Concurrent Session B: Renal Hemodynamics and Chronic Kidney Disease Concurrent C 3:30 – 4:30 p.m. 3:30 3:45 4:00 4:15 4:30 – 5:30 p.m. 4:30 4:45 5:00 5:30 |
5:45 pm to 6:15 pm | Session 18 Excellence Award for Hypertension Research Lecture |
7:00 pm to 10:00 pm | Council Awards Banquet (Ticketed Event) |
Time | Activity |
---|---|
8:00 am to 9:30 am |
Session 19 Concurrent A: Renal Tubular Transport Invited Lecture: Tubular Transport Concurrent B: Diabetes and Obesity Invited Lecture: Diabetes and Obesity Concurrent C 8:00 – 8:45 Presenters: 8:45- 9:30 8:45 8:50 9:00 9:10 - 9:30 |
9:30 am to 10:00 am | Break |
10:00 am to 11:30 am |
Session 20 Concurrent A: Genetics and Metabolomics Invited Lecture: Genetics/Metabolomics Concurrent B: Pediatric Hypertension Concurrent C: Blood Pressure Control and Adherence to Treatment Invited Lecture: Blood Pressure and Adherence |
11:30 am to 12:00 pm | Closing Keynote Lecture R. Ariel Gomez, MD, FAHA |
About This Meeting
Hypertension 2025 Scientific Sessions is considered the premier scientific meeting on the subject in the world. A collaborative effort between the Council on Hypertension and the Council on the Kidney in Cardiovascular Disease, the science submitted to this conference continues to bring us the most up to date developments on our understanding of: the causes of hypertension; its relationship to stroke, cardiac disease and kidney dysfunction; and the most effective means for detecting, evaluating and treating high blood pressure across diverse populations.
This year's programming also includes:
- Recent Advances sessions and lectures on cutting-edge science, followed by oral abstract presentations
- Clinical Science/Clinical Practice track
- Primary Care track
- Oral abstract sessions highlighting Early Career oral abstract presentations
- Networking sessions
- Trainee Advocacy Committee (TAC) Poster session and competition
- Award Lecture sessions
Learning Objectives
- Discuss recent advances and emerging experimental models in hypertension and kidney disease.
- Summarize findings from recent clinical trials and the impact on future treatment and/or management of hypertensive and kidney-related disorders.
- Describe new therapeutic options and technologies for patients with hypertension and kidney disease.
- Describe the most up-to-date clinical guideline recommendations for the prevention, diagnosis, and management of hypertension and kidney disease.